BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24747435)

  • 1. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.
    Wang Y; Gu X; Zhang G; Wang L; Wang T; Zhao Y; Zhang X; Zhou Y; Kadin M; Tu P
    Blood; 2014 May; 123(22):3452-61. PubMed ID: 24747435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
    Gao Y; Liu F; Sun J; Wen Y; Tu P; Kadin ME; Wang Y
    J Invest Dermatol; 2021 Mar; 141(3):607-618.e6. PubMed ID: 32771472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
    Buchan SL; Al-Shamkhani A
    PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma.
    Grzanka D; Gagat M; Izdebska M; Marszałek A
    Oncol Rep; 2015 Jan; 33(1):250-66. PubMed ID: 25384658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
    Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
    J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.
    Scarisbrick JJ
    Future Oncol; 2017 Nov; 13(27):2405-2411. PubMed ID: 28805086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.
    Kamijo H; Sugaya M; Takahashi N; Oka T; Miyagaki T; Asano Y; Sato S
    Arch Dermatol Res; 2017 Aug; 309(6):491-497. PubMed ID: 28593508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].
    Hirsch B; Braun FK; Al-Yacoub N; Assaf C; Kadin ME; Sterry W; Eberle J; Dürkop H
    Pathologe; 2010 Oct; 31 Suppl 2():193-8. PubMed ID: 20812013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).
    Zu G; Yao J; Ji A; Ning S; Luo F; Li Z; Feng D; Rui Y; Li Y; Wang G; Tian X
    J Mol Med (Berl); 2017 Jan; 95(1):83-95. PubMed ID: 27553040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
    Velusamy T; Kiel MJ; Sahasrabuddhe AA; Rolland D; Dixon CA; Bailey NG; Betz BL; Brown NA; Hristov AC; Wilcox RA; Miranda RN; Medeiros LJ; Jeon YK; Inamdar KV; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Dec; 124(25):3768-71. PubMed ID: 25349176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases.
    Takahashi E; Tsuchida T; Baba S; Tsuzuki T; Shimauchi T; Tokura Y; Tamada Y; Nakamura S
    Pathol Int; 2020 Oct; 70(10):804-811. PubMed ID: 32783303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATB1 in Malignant T Cells.
    Fredholm S; Willerslev-Olsen A; Met Ö; Kubat L; Gluud M; Mathiasen SL; Friese C; Blümel E; Petersen DL; Hu T; Nastasi C; Lindahl LM; Buus TB; Krejsgaard T; Wasik MA; Kopp KL; Koralov SB; Persson JL; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Becker JC; Ødum N
    J Invest Dermatol; 2018 Aug; 138(8):1805-1815. PubMed ID: 29751003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas.
    van Haselen CW; Vermeer MH; Toonstra J; van der Putte SC; Mulder PG; van Vloten WA; Willemze R
    J Cutan Pathol; 1997 Sep; 24(8):462-7. PubMed ID: 9331891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation.
    Li G; Salhany KE; Rook AH; Lessin SR
    J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.